Surmodics | SRDX - Attività





Attività Cambiamento Data
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.31B 80.48M 2026-03
Anika Therapeutics USD 179.39M 10.88M 2026-03
Arrowhead Research USD 2.27B 664.08M 2026-03
Artivion USD 883.16M 1.64M 2026-03
Baxter International USD 19.85B 209M 2026-03
Boston Scientific USD 44.35B 678M 2026-03
EDAP TMS EUR 61.46M 6.88M 2025-09
Edwards Lifesciences USD 13.32B 376M 2026-03
Haemonetics USD 2.4B 94.96M 2026-03
Heron Therapeutics USD 246.22M 9.66M 2026-03
J&J USD 200.89B 1.68B 2026-03
Merit Medical Systems USD 2.72B 33.36M 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Option Care Health USD 3.38B 75.67M 2026-03
Stryker USD 46.29B 1.55B 2026-03
Surmodics USD 169.82M 8.74M 2025-06
Trinity Biotech USD 103.71M 4.08M 2025-09